Curia Appoints Philip Macnabb CEO

Curia, a contract research development and manufacturing organization (CDMO), has named Philip Macnabb chief executive officer, succeeding John Ratliff.

“On behalf of the Board of Directors, we thank John Ratliff for the tremendous progress that Curia made during his tenure,” said Curia board members Sean Cunningham, managing director, GTCR and William McMullan, managing director, Carlyle, in a statement.

“We are delighted to welcome Phil, a seasoned executive who has an impressive track record of focusing companies on their core value proposition, enhancing the customer experience and building organizations with real and sustaining value. Curia is well positioned in the growing CDMO market, and we are excited about its outlook under Phil’s leadership.”

Macnabb said: “Curia is a unique company with deep scientific expertise across its end-to-end offering. We have incredible people in the global Curia community, who are highly motivated by our noble purpose of improving patients’ lives. Going forward, we will focus on creating sustainable value for customers and employees.”

Macnabb joins Curia after having held leadership roles at various companies in the healthcare industry. Macnabb also held senior positions in technology, distribution, and consumer products segments.